BiomX shareholders approve reverse stock split authorization and elect Class II directors

BiomX Inc.

Elected Susan Blum, Dr. Jesse Goodman, and Gregory Merril as Class II directors until 2028.
Approved board authority to reverse split common stock at a ratio between 1-for-5 and 1-for-20 (13.6M votes for, 383.7K against).
Ratified Kesselman & Kesselman (PwC member) as independent auditor for fiscal 2025 with 14.05M votes for.
Adjournment proposal not called due to sufficient votes on other proposals.
All three proposals passed; broker non-votes were zero on director elections.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.